201 related articles for article (PubMed ID: 15987458)
1. CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.
Chang JH; Gertig DM; Chen X; Dite GS; Jenkins MA; Milne RL; Southey MC; McCredie MR; Giles GG; Chenevix-Trench G; Hopper JL; Spurdle AB
Breast Cancer Res; 2005; 7(4):R513-21. PubMed ID: 15987458
[TBL] [Abstract][Full Text] [Related]
2. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.
Haiman CA; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
Cancer Res; 1999 Mar; 59(5):1015-20. PubMed ID: 10070957
[TBL] [Abstract][Full Text] [Related]
3. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
[TBL] [Abstract][Full Text] [Related]
4. CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.
Einarsdóttir K; Rylander-Rudqvist T; Humphreys K; Ahlberg S; Jonasdottir G; Weiderpass E; Chia KS; Ingelman-Sundberg M; Persson I; Liu J; Hall P; Wedrén S
Breast Cancer Res; 2005; 7(6):R890-6. PubMed ID: 16280037
[TBL] [Abstract][Full Text] [Related]
5. A polymorphism in the CYP17 gene increases the risk of breast cancer.
Feigelson HS; Coetzee GA; Kolonel LN; Ross RK; Henderson BE
Cancer Res; 1997 Mar; 57(6):1063-5. PubMed ID: 9067272
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism of CYP17 and breast cancer risk in Korean women.
Shin MH; Lee KM; Yang JH; Nam SJ; Kim JW; Yoo KY; Park SK; Noh DY; Ahn SH; Kim B; Kang D
Exp Mol Med; 2005 Feb; 37(1):11-7. PubMed ID: 15761247
[TBL] [Abstract][Full Text] [Related]
7. Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.
Mitrunen K; Jourenkova N; Kataja V; Eskelinen M; Kosma VM; Benhamou S; Vainio H; Uusitupa M; Hirvonen A
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1343-8. PubMed ID: 11142420
[TBL] [Abstract][Full Text] [Related]
8. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.
Ye Z; Parry JM
Mutagenesis; 2002 Mar; 17(2):119-26. PubMed ID: 11880540
[TBL] [Abstract][Full Text] [Related]
9. CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors.
Ambrosone CB; Moysich KB; Furberg H; Freudenheim JL; Bowman ED; Ahmed S; Graham S; Vena JE; Shields PG
Breast Cancer Res; 2003; 5(2):R45-51. PubMed ID: 12631398
[TBL] [Abstract][Full Text] [Related]
10. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.
Spurdle AB; Hopper JL; Dite GS; Chen X; Cui J; McCredie MR; Giles GG; Southey MC; Venter DJ; Easton DF; Chenevix-Trench G
J Natl Cancer Inst; 2000 Oct; 92(20):1674-81. PubMed ID: 11036113
[TBL] [Abstract][Full Text] [Related]
11. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.
Haiman CA; Stampfer MJ; Giovannucci E; Ma J; Decalo NE; Kantoff PW; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):743-8. PubMed ID: 11440959
[TBL] [Abstract][Full Text] [Related]
12. CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women.
Henningson M; Johansson U; Borg A; Olsson H; Jernström H
Mol Hum Reprod; 2007 Apr; 13(4):231-6. PubMed ID: 17307805
[TBL] [Abstract][Full Text] [Related]
13. The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women.
McCann SE; Moysich KB; Freudenheim JL; Ambrosone CB; Shields PG
J Nutr; 2002 Oct; 132(10):3036-41. PubMed ID: 12368392
[TBL] [Abstract][Full Text] [Related]
14. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island.
Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM
Breast J; 2011; 17(1):24-31. PubMed ID: 21129090
[TBL] [Abstract][Full Text] [Related]
15. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
18. CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study.
Antognelli C; Del Buono C; Ludovini V; Gori S; Talesa VN; Crinò L; Barberini F; Rulli A
BMC Cancer; 2009 Apr; 9():115. PubMed ID: 19379515
[TBL] [Abstract][Full Text] [Related]
19. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.
Mao C; Wang XW; He BF; Qiu LX; Liao RY; Luo RC; Chen Q
Breast Cancer Res Treat; 2010 Jul; 122(1):259-65. PubMed ID: 20033766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]